Contract 36F79721D0244
Hema Biologics Llc · Department Of Veterans Affairs · September 2, 2021
Hema Biologics Llc was awarded a federal contract by Department Of Veterans Affairs on September 2, 2021 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 9 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 27, 2026. If all options are exercised, the contract could reach $225,000.
Contract details
- PIID
- 36F79721D0244
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 2, 2021
- Latest action
- March 27, 2026
Description
PRODUCT ADDITION
Modification timeline
-
March 27, 2026Mod P00010$0
-
December 30, 2025Mod P00009POC CHANGE AND UPDATE TO SIGNATORY AUTHORITY$0
-
November 26, 2025Mod P000082026 PUBLIC LAW PRICING UPDATE$0
-
December 2, 2024Mod P00007PUBLIC LAW 2025$0
-
December 13, 2023Mod P000062024 PUBLIC LAW$0
-
November 30, 2022Mod P00005PUBLIC LAW PRICING UPDATE$0
-
January 4, 2022Mod P00004TPR-SEVENFACT$0
-
December 10, 2021Mod P00003PUBLIC LAW 2022 UPDATE$0
-
September 22, 2021Mod P00001TPR$0
-
September 2, 2021Base award65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79721D0244?
Contract 36F79721D0244 is a federal contract awarded to Hema Biologics Llc by Department Of Veterans Affairs on September 2, 2021 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 9 times since the base award.
Who won contract 36F79721D0244?
Hema Biologics Llc won contract 36F79721D0244 from Department Of Veterans Affairs.
How much is contract 36F79721D0244 worth?
Contract 36F79721D0244 has obligated $0 to date but carries a potential ceiling of $225,000 if fully funded and all options are exercised.